Schmitt F - Search Results

1

Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study.

Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ. Mackell JA, et al. Among authors: schmitt f. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S65-9. Alzheimer Dis Assoc Disord. 1997. PMID: 9236955 Clinical Trial.

2

Designing a Brief Alzheimer Screen (BAS).

Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Mendiondo MS, et al. J Alzheimers Dis. 2003 Oct;5(5):391-8. doi: 10.3233/jad-2003-5506. J Alzheimers Dis. 2003. PMID: 14646030

3

Measuring treatment response in Alzheimer's disease clinical trials.

Caban-Holt A, Bottiggi K, Schmitt FA. Caban-Holt A, et al. Geriatrics. 2005 Jun;Suppl:3-8. Geriatrics. 2005. PMID: 16025769 Review.

4

Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease.

Galasko D, Schmitt F, Thomas R, Jin S, Bennett D; Alzheimer's Disease Cooperative Study. Galasko D, et al. Among authors: schmitt f. J Int Neuropsychol Soc. 2005 Jul;11(4):446-53. doi: 10.1017/s1355617705050502. J Int Neuropsychol Soc. 2005. PMID: 16209425

5

Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis.

Schmitt FA, van Dyck CH, Wichems CH, Olin JT; Memantine MEM-MD-02 Study Group. Schmitt FA, et al. Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):255-62. doi: 10.1097/01.wad.0000213860.35355.d4. Alzheimer Dis Assoc Disord. 2006. PMID: 17132970 Clinical Trial.

6

Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.

Feldman HH, Schmitt FA, Olin JT; Memantine MEM-MD-02 Study Group. Feldman HH, et al. Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):263-8. doi: 10.1097/01.wad.0000213859.35355.59. Alzheimer Dis Assoc Disord. 2006. PMID: 17132971 Clinical Trial.

7

ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions.

Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. Schneider LS, et al. Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S124-38. doi: 10.1097/01.wad.0000213878.47924.44. Alzheimer Dis Assoc Disord. 2006. PMID: 17135806

8

Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL; Alzheimer's Disease Cooperative Study Group. Lu PH, et al. Neurology. 2009 Jun 16;72(24):2115-21. doi: 10.1212/WNL.0b013e3181aa52d3. Neurology. 2009. PMID: 19528519 Free PMC article. Clinical Trial.

9

Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials.

Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, Morris JC, Reisberg B, Petersen RC, Ferris SH. Schneider LS, et al. Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):260-7. doi: 10.1097/WAD.0b013e31819cb760. Alzheimer Dis Assoc Disord. 2009. PMID: 19812469 Free PMC article.

10

"End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?

Abner EL, Kryscio RJ, Schmitt FA, Santacruz KS, Jicha GA, Lin Y, Neltner JM, Smith CD, Van Eldik LJ, Nelson PT. Abner EL, et al. J Alzheimers Dis. 2011;25(3):445-53. doi: 10.3233/JAD-2011-101980. J Alzheimers Dis. 2011. PMID: 21471646 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,337 results

Search Page

Filters